Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the firm, Marketbeat ...

The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related ...